Modus Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-480
Closed -$29.8K – 208
2025
Q4
$29.8K Buy
+480
New +$29.6K 0.01% 208
2025
Q1
– Sell
-480
Closed -$28K – 194
2024
Q4
$28K Buy
+480
New +$28.5K 0.01% 184
2021
Q3
– Sell
-1,200
Closed -$72K – 159
2021
Q2
$72K Buy
+1,200
New +$69.4K 0.03% 135
2020
Q3
– Sell
-3,900
Closed -$172K – 142
2020
Q2
$172K Sell
3,900
-1,548
-28% -$66.2K 0.11% 82
2020
Q1
$205K Sell
5,448
-300
-5% -$12.6K 0.19% 62
2019
Q4
$253K Buy
+5,748
New +$242K 0.2% 59

Other funds holding IHI

Modus Advisors's IHI Position: Q1 2026 in Review

Modus Advisors sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 480 shares — an estimated $29.8K sold.

Modus Advisors first reported a position in IHI in Q4 2019 and held it in 6 quarters. The position peaked at $253K in Q4 2019. 512 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Modus Advisors reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
  • Modus Advisors sold 480 iShares US Medical Devices ETF shares in Q1 2026, an estimated $29.8K.
  • Modus Advisors first reported a position in iShares US Medical Devices ETF in Q4 2019 and held it in 6 quarters.
  • Modus Advisors's iShares US Medical Devices ETF position peaked at $253K in Q4 2019.
  • 512 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.